Lv3
334 积分 2025-04-30 加入
Beyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug development
9小时前
待确认
Nonclinical Testing Evaluation of Liposomes as Drug Delivery Systems
11天前
已完结
Managing efficacy and toxicity of drugs: Targeted delivery and excretion
11天前
已完结
Artificial intelligence in drug discovery — what it is, where we stand and the path forward
17天前
已完结
Nonclinical safety evaluation of sunitinib: a potent inhibitor of VEGF, PDGF, KIT, FLT3, and RET receptors
1个月前
已完结
Characterization of an anti-STEAP1 T-cell dependent bispecific antibody for the treatment of prostate cancer and associated toxicity in cynomolgus monkeys
1个月前
已完结
A comprehensive review of humanized mice applications in regulatory submissions for cell and gene therapy products
1个月前
已完结
Nonclinical safety evaluation strategies for mRNA/LNPs platform agents: Evidence from comprehensive animal toxicity studies
2个月前
已完结
BLT-Immune Humanized Mice as a Model for Nivolumab-Induced Immune-Mediated Adverse Events: Comparison of the NOG and NOG-EXL Strains
2个月前
已完结
Nonclinical Safety, Pharmacokinetics, and Pharmacodynamics of Atacicept
3个月前
已完结
皖公网安备34019202002308
